Drugs / ND1.1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01698060 | Sep 2012 → Nov 2013 | avian influenza | Vaxart | Completed | No outcome recorded |
| Phase 1 | NCT01335347 | Apr 2011 → Aug 2012 | avian influenza | Vaxart | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ND1.1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01335347 ↗ |
| Modality | Vaccine | “The purpose of this study is to demonstrate the safety and immunogenicity of an oral vaccine to prevent avian influenza.” NCT01335347 ↗ |
| Route | Oral | “orally delivered avian influenza vaccine” PMID 23357198 ↗ Jan 2013 |